Evidence map›Paper›PMID 39013021›Full record

ArticleACS applied materials & interfaces2024

Decoupling Fluorous Protein Coatings Yield Heat-Stable and Intrinsically Sterile Bioformulations.

Harminder Singh, Atip Lawanprasert, Utkarsh, Sopida Pimcharoen, Arshiya Dewan, Dane Rahoi, Girish S Kirimanjeswara, Scott H Medina

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Harminder SinghDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.ORCID 0000-0001-9261-6651
Atip LawanprasertDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.
UtkarshDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.
Sopida PimcharoenDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.
Arshiya DewanDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.
Dane RahoiAnimal Diagnostics Laboratory, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.
Girish S KirimanjeswaraDepartment of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.
Scott H MedinaDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802-4400, United States.ORCID 0000-0001-5441-2164

Funding

Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Understanding and controlling the cellular fate of fluorine-modified biologicsR35GM142902 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Scott Hammond Medina · 2021 to 2026
$2.2M
TA Instruments Low Volume AutoAffinity ITCS10OD025145 · OD · PENNSYLVANIA STATE UNIVERSITY, THE · PI YENNAWAR, NEELA H. · 2018 to 2018
$247k
NIGMS NIH HHS P41 GM103311NIGMS NIH HHS R35 GM142902NIH HHS S10 OD025145
6 · The paper itself

Abstract

Thermal inactivation is a major bottleneck to the scalable production, storage, and transportation of protein-based reagents and therapies. Failures in temperature control both compromise protein bioactivity and increase the risk of microorganismal contamination. Herein, we report the rational design of fluorochemical additives that promiscuously bind to and coat the surfaces of proteins to enable their stable dispersion within fluorous solvents. By replacing traditional aqueous liquids with fluorinated media, this strategy conformationally rigidifies proteins to preserve their structure and function at extreme temperatures (≥90 °C). We show that fluorous protein formulations resist contamination by bacterial, fungal, and viral pathogens, which require aqueous environments for survival, and display equivalent serum bioavailability to standard saline samples in animal models. Importantly, by designing dispersants that decouple from the protein surface in physiologic solutions, we deliver a fluorochemical formulation that does not alter the pharmacologic function or safety profile of the functionalized protein

Indexed as

Hot TemperatureAnimalsCoated Materials, BiocompatibleMiceProteinsCoated Materials, BiocompatibleProteinsbiotherapeuticsfluorine chemistryperfluorocarbonprotein formulationprotein stabilityprotein structure

Identifiers

PMID39013021
PMCPMC11299136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.